بيكالوتاميد تيڤع ١٥٠ ملغ
teva pharmaceutical indust.ltd - bicalutamide 150 mg - tablets - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.
أبيترن ٥٠
abic ltd. - diclofenac sodium 50 mg - suppositories - diclofenac - rheumatoid arthritis, osteoarthritis, low back pain and other acute musculoskeletal .disorders such as periarthritis, tendinitis, tenosynovitis, bursitis, sprains, strains and dislocation, ankylosing spondylitis and acute gout.control of pain and inflammation in orthopedic, dental, and other monor surgery.
دوﻧپيزيل تيڤع ١٠ ملغ
teva pharmaceutical indust.ltd - donepezil hydrochloride 5 mg - tablets - donepezil - treatment of mild to moderately severe alzheimer's dementia.
لوساردكس٥٠
dexcel pharma technologies ltd - losartan potassium 50 mg - tablets - losartan - hypertension: losardex is indicated for the treatment of hypertension. heart failure: losardex is indicated for the treatment of heart failure (nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to losardex is not recommended. renal protection in type-2 diabetic patients with proteinuria: losardex is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventric
multidermol infantil pomada protectora 50 g
inhixa 100 mg (10000 ui) 30 xeringues precarregades 1 ml (agulla amb protector)
inhixa 60 mg (6000 ui) 30 xeringues precarregades 0,6 ml (agulla amb protector)
inhixa 150 mg (15000 ui) 30 xeringues precarregades 0,8 ml (agulla amb protector)
inhixa 120 mg (12000 ui) 30 xeringues precarregades 0,8 ml (agulla amb protector)
inhixa 80 mg 8000 ui 30 xeringues 0,8 ml (agulla amb protector)